Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms

Curr Med Res Opin. 2017 Jul;33(7):1349-1351. doi: 10.1080/03007995.2017.1322571. Epub 2017 May 19.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bifidobacterium
  • Bifidobacterium longum subspecies infantis*
  • Humans
  • Irritable Bowel Syndrome*
  • Probiotics
  • Sensitivity and Specificity
  • Treatment Outcome